Publications by authors named "Michael Chandra"
Article Synopsis
- Effective therapies for nonmuscle invasive bladder cancer following BCG treatment are inadequate, prompting many clinical trials focusing on this patient group.
- A systematic analysis of clinical trial enrollment criteria showed significant variability, which might prevent eligible patients from participating in ongoing studies.
- Of the 31 examined trials, only 48% included patients who met the FDA's BCG unresponsive criteria, indicating a mismatch between patient needs and trial accessibility.
We reevaluate the predictive accuracy of intravascular ultrasound (IVUS)-derived per cent plaque area stenosis (PAS) in significant coronary lesions (CLs) with or without proximal and distal reference vessel area adjustment. IVUS is valuable in defining moderate CL severity (30 to 70%) in left main (LM) or non-left main (NLM) coronaries using minimum luminal area (MLA) of ≤5.9 and ≤4 mm(2), respectively.
View Article and Find Full Text PDF